F.D.A. Rule Limits Role of Advisers Tied to Industry - New York Times

F.D.A. Rule Limits Role of Advisers Tied to Industry - New York Times:

"Expert advisers to the government who receive money from a drug or device maker would be barred for the first time from voting on whether to approve that company’s products under new rules announced Wednesday for the F.D.A.’s powerful advisory committees.

Indeed, such doctors who receive more than $50,000 from a company or a competitor whose product is being discussed would no longer be allowed to serve on the committees, though those who receive less than that amount in the prior year can join a committee and participate in its discussions."